From $1 to $8? Why Analyst Experts Are Bullish on Cardiol

Sometimes stock market performance doesn’t line up with the fundamentals of a…

Aduro Clean Technologies: Analyst’s $50 Price Target Could Be Just the Beginning

Aduro Clean Technologies (NASDAQ: ADUR) (CSE: ACT) (FSE: 9D50) is gaining momentum…

Small Pharma, Big Gains: The Power of Clinical Trial Results

For smaller pharmaceutical companies, valuation can be greatly impacted by progression in…